C-20.. you are right , our CD-10 was a success ,
We are in phase 2 study , Clinically Significant in primary endpoints , and Statistically Significant in much more significant secondary endpoints , designed by Royal College of Physicians in England , NEWS2.
I dont know of any other study with the biggest BP , accomplishing that without changing few times primary endpoints..
IMO..